Company / Cost of Revenue
SOLENO THERAPEUTICS INC Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$2.7M
FY2025
5-year range
$2.7M / $2.7M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#75 of 83
Health Care
What the data says
Among 83 Health Care companies, SOLENO THERAPEUTICS INC is in the top 10% for cost of revenue.
Based on SEC 10-K filings.
$3M in FY2025.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 83This company $2.7M Sector average $2.0B
▼
-99.9% below sector average
Key checks
Key Insights
- Ranks #75 out of 83 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $1.5M | +327.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026